Vaxneuvance, Injektionssuspension
7680687520010
CH-68752
Injektionssuspension
Associated product:
VAXNEUVANCE susp inj ser pré 0.5 ml
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Fertigspritze(n)
- Galenic form
- Injektionssuspension
- Galenic group
- Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
2.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
2.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
2.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
2.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
2.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
4.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
2.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
2.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
2.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
2.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
2.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
2.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
2.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
2.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
2.0 UG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
32.0 UG | Substance | WIIS |
|
(N/A)
|
- | Substance | WIIS |
|
(N/A)
|
0.125 MG | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
1.77 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 79.80
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/04/2023
Authorization holder
MSD Merck Sharp & Dohme AG
6005 Luzern
Authorization information
- Swissmedic authorization number
- 68752
- Drug name
- Vaxneuvance, Injektionssuspension
- Galenic form
- INJFS
- ATC Code
- J07AL02
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 14/02/2023
- Authorization expiration date
- 13/02/2028
- IT Number
- 08.08.
- Domain
- Human medicine
Package details
- Description (FR)
- VAXNEUVANCE sol inj 2 µg 1 pce
- Description (DE)
- VAXNEUVANCE Inj Lös 2 µg 1 Stk
- Market launch
- 14/02/2023
- Narcotic (BTM)
- No
Other package sizes (1)
VAXNEUVANCE sol inj 2 µg 10 pce
10 FESP
GTIN: 7680687520027